Breast Cancer Profiling Project, Drug Sensitivity phase II: Fixed-cell GR measures of 33 breast cell lines and PDX lines to 16 small molecule perturbagens from library plate II. Dataset 1 of 2: Normalized growth rate inhibition values - Dataset (ID:20354)
Download: Excel (XLSX), Comma-separated (CSV)
| Cell | Small Molecule | Small Mol Concentration (uM) | Mean Normalized Growth Rate Inhibition Value | Increased Fraction Dead |
|---|---|---|---|---|
| HCC1395 | Rucaparib | 0.001 | 1.0402 | 0.00554 |
| HCC1395 | Rucaparib | 0.001 | 0.7275 | -0.01163 |
| HCC1395 | Rucaparib | 0.001 | 0.7082 | 0.00017 |
| HCC1395 | Rucaparib | 0.00316227766017 | 0.6594 | 0.03226 |
| HCC1395 | Rucaparib | 0.00316227766017 | 1.0813 | -0.00270 |
| HCC1395 | Rucaparib | 0.00316227766017 | 0.7975 | 0.00553 |
| HCC1395 | Rucaparib | 0.01 | 0.7543 | -0.00010 |
| HCC1395 | Rucaparib | 0.01 | 0.4864 | 0.00613 |
| HCC1395 | Rucaparib | 0.01 | 0.6019 | 0.00526 |
| HCC1395 | Rucaparib | 0.0316227766017 | 0.5389 | 0.00855 |
| HCC1395 | Rucaparib | 0.0316227766017 | 0.5726 | -0.00490 |
| HCC1395 | Rucaparib | 0.0316227766017 | 0.6122 | 0.05013 |
| HCC1395 | Rucaparib | 0.1 | 0.4995 | 0.02949 |
| HCC1395 | Rucaparib | 0.1 | 0.7736 | 0.00892 |
| HCC1395 | Rucaparib | 0.1 | 0.5214 | 0.01342 |
| HCC1395 | Rucaparib | 0.316227766017 | 0.4806 | 0.02039 |
| HCC1395 | Rucaparib | 0.316227766017 | 0.8379 | 0.00711 |
| HCC1395 | Rucaparib | 0.316227766017 | 0.6446 | 0.00747 |
| HCC1395 | Rucaparib | 1.0 | 0.6653 | 0.01788 |
| HCC1395 | Rucaparib | 1.0 | 0.8499 | -0.01276 |
| HCC1395 | Rucaparib | 1.0 | 0.4139 | 0.02933 |
| HCC1395 | Rucaparib | 3.16227766017 | 0.4067 | 0.01763 |
| HCC1395 | Rucaparib | 3.16227766017 | 0.6417 | 0.02036 |
| HCC1395 | Rucaparib | 3.16227766017 | 0.2606 | 0.00507 |
| HCC1395 | Rucaparib | 10.0 | 0.2464 | 0.02288 |